Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Nano-X Imaging ( (NNOX) ) just unveiled an update.
On April 20, 2026, Nano-X Imaging reported fourth-quarter 2025 revenue of $3.7 million, up from $3.0 million a year earlier, driven mainly by growth in teleradiology and AI and software services following the November 19, 2025 acquisition of Vaso Healthcare IT Corp. The company still posted a net loss of $33.4 million versus $14.1 million a year earlier, largely due to a $17.5 million impairment tied to restructuring its South Korean semiconductor manufacturing facility to cut costs and improve future gross margins.
Commercially, Nanox advanced U.S. deployment of its Nanox.ARC systems, signing a distribution deal with Howard Technology Solutions to deploy 300 units over three years and executing agreements covering roughly 360 capital-expenditure systems over the next two to three years. The business also expanded clinical and regulatory work, including a Cedars Sinai trial for its aortic valve calcification AI, while management announced a planned CFO transition from Ran Daniel to Guy Nathanzon in mid-2026 and noted that, despite regional geopolitical tensions, global operations had not yet faced material disruptions.
The most recent analyst rating on (NNOX) stock is a Buy with a $7.00 price target. To see the full list of analyst forecasts on Nano-X Imaging stock, see the NNOX Stock Forecast page.
Spark’s Take on NNOX Stock
According to Spark, TipRanks’ AI Analyst, NNOX is a Neutral.
The score is primarily held down by weak financial performance—negative gross profit, large ongoing losses, and sustained cash burn—despite a low-debt balance sheet. Technicals also remain soft with the stock below key moving averages and negative MACD. Positive earnings-call guidance and expansion initiatives provide some upside, but are tempered by continued losses and regulatory/expense headwinds.
To see Spark’s full report on NNOX stock, click here.
More about Nano-X Imaging
Nano-X Imaging Ltd, based in Petach Tikva, Israel, is an innovative medical imaging technology company focused on its flagship Nanox.ARC X-ray system, teleradiology services and AI-driven imaging software. The company is expanding commercialization primarily in the U.S. market through direct sales and distribution partnerships, while also building capabilities in healthcare IT via its Nanox Health IT unit.
Average Trading Volume: 979,357
Technical Sentiment Signal: Sell
Current Market Cap: $165.1M
Find detailed analytics on NNOX stock on TipRanks’ Stock Analysis page.